Oppenheimer Increased its Price Target on Amrize Ltd (AMRZ) to $70 and Maintains an Outperform Rating
On February 19, 2026, Oppenheimer increased its price target on Amrize Ltd (NYSE:AMRZ) to $70 from $64 and maintained an Outperform rating.
Amrize Ltd (AMRZ)
Market is closed
Sector: Cement, Hydraulic
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Harris Associates Natixis Global Asset Management | 11,379,547 | $615,405,896 | 0.78% | |
| 2. | Slate Path Capital David Greenspan | 5,859,119 | $316,861,156 | -5% | 4.27% |
| 3. | First Pacific Advisors LLC Robert Rodriguez And Steven Romick | 3,408,072 | $184,308,534 | 2.43% | |
| 4. | Gates Capital Management Jeffrey Gates | 2,444,508 | $132,198,993 | -23% | 3.48% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,339,304 | $128,661,720 | -20% | 0.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $63.91 | 205 | $13,101.55 | 18,544 | 2026-02-19 | Filing | |
| $63.92 | 995 | $63,600.40 | 18,339 | 2026-02-19 | Filing | |
| $47.34 | 2,000 | $94,680.00 | 4,958 | 2025-11-19 | Filing | |
| $50.69 | 4,000 | $202,740.00 | 18,101 | 2025-11-04 | Filing | |
| $51.76 | 1,000 | $51,760.00 | 9,000 | 2025-10-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 31,770,926 | $1,722,500,397 | 0.02% | |
| 2. | 16,926,762 | $929,332,833 | 0.1% | |
| 3. | 14,198,404 | $767,849,688 | 0.01% | |
| 4. | 13,465,806 | $728,230,788 | 0.12% | |
| 5. | 12,718,217 | $698,527,963 | 0.12% |
News See All
Amrize Ltd (NYSE:AMRZ) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Amrize Q4 2025 Earnings Conference Call. [Operator Instructions] Also as a reminder, this conference is being recorded today.
What Makes Amrize (AMRZ) a Strong Investment?
Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” fourth-quarter 2025 investor letter. The objective of the fund is to deliver capital appreciation by investing in diverse...
Amrize Ltd (NYSE:AMRZ) Q3 2025 Earnings Call Transcript
Operator: Hello, and welcome to Amrize Q3 2025 Earnings Conference Call. [Operator Instructions] Also, as a reminder, this conference is being recorded today.
Amrize AG (AMRZ) Downplays TRC Capital Tender Offer
Amrize Ltd (NYSE:AMRZ) is one of the best cement stocks to buy according to analysts.
7 Best Cement Stocks to Buy According to Analysts
Cement is a key material in the construction industry and an essential indicator of economic growth. Its demand is always high whenever there are heightened efforts to expand infrastructure.
Oppenheimer Initiates Coverage of Amrize (AMRZ) with Outperform Rating, Cites Growth Strategy, Strong Financials
Amrize (NYSE:AMRZ) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Oppenheimer analyst Bryan F.
15 Best IPO Stocks to Buy and Hold For 3 Years
On August 15, Rick Heitzmann, FirstMark Capital founder and partner, joined 'Closing Bell' on CNBC to discuss the hot streak in the IPO market.
Here are Bronte Capital’s Views on Amrize Ltd (AMRZ)
Bronte Capital, an investment management company, released its “Amalthea Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here.